BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma

Clinical trial NCT03469557 · COMPLETED

Trial details

NCT number

NCT03469557

Sponsor

BeiGene

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2017-07-18

Primary completion

2019-03-31

Enrollment

30

View on ClinicalTrials.gov